Cleared Traditional

VitalScan ANS (K191266) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K191266 · Medeia, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2020
Decision
250d
Days
Class 2
Risk

K191266 is an FDA 510(k) clearance for the VitalScan ANS. Classified as Plethysmograph, Photoelectric, Pneumatic Or Hydraulic (product code JOM), Class II - Special Controls.

Submitted by Medeia, Inc. (Santa Barbara, US). The FDA issued a Cleared decision on January 15, 2020 after a review of 250 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2780 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medeia, Inc. devices

Submission Details

510(k) Number K191266 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2019
Decision Date January 15, 2020
Days to Decision 250 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
125d slower than avg
Panel avg: 125d · This submission: 250d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JOM Plethysmograph, Photoelectric, Pneumatic Or Hydraulic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Compliance and Regulatory Services, LLC
Daniel Lehtonen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - JOM Plethysmograph, Photoelectric, Pneumatic Or Hydraulic

Devices cleared under the same product code (JOM) and FDA review panel - the closest regulatory comparables to K191266.
MESI mTABLET TBI diagnostic system, MESI mTABLET TBI
K213730 · Mesi, Development of Medical Devices, Ltd.; Mesi D.O.O. · Apr 2022
ASI Plethysmogrpah Analyzer
K200567 · Arterial Stiffness, Inc. · Feb 2021
Automated ankle brachial pressure index measuring device, MESI mTABLET system
K201046 · Mesi D.O.O.; Mesi, Development of Medical Devices, Ltd. · Dec 2020
Automated ankle brachial pressure index measuring device
K172655 · Mesi D.O.O.; Mesi, Development of Medical Devices, Ltd. · Jan 2018